Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Regeneron Pharmaceuticals, Inc.
(NQ:
REGN
)
263.64
USD
-3.33 (-1.25%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Regeneron Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
44
45
Next >
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap.
Read More
category
companyNews
from
Reuters: Company News
Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356010 for the full story.
Read More
from
StreetInsider.com News Articles
Earnings Look Back: Regeneron Pharmaceuticals Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (REGN)
May 20, 2013
from
Comtex SmarTrend® News Briefs
UBS Starts Regeneron Pharma (REGN) at Neutral
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349692 for the full story.
Read More
from
StreetInsider.com News Articles
Watch for Continued Gains in Shares of Regeneron Pharmaceuticals (REGN)
May 15, 2013
from
Comtex SmarTrend® News Briefs
Critical Alerts For SanDisk, Computer Sciences, American Tower Corp, Questcor Pharmaceuticals, and Regeneron Pharmaceuticals Released By InvestorsObserver
May 15, 2013
from
PR Newswire
NASDAQ Active Stock Watch List: Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), and XOMA Corporation (NASDAQ:XOMA) Added to Equity Profile Report's NASDAQ Act
May 15, 2013
Wilmington, DE -- (SBWIRE) -- 05/15/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Regeneron Pharmaceuticals, Inc....
Read More
from
SBWire - Latest Press Releases
Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), and XOMA Corporation (NASDAQ:XOMA) Added to Growing Stock Report's NASDAQ Active Stock Watch List
May 15, 2013
New York, NY -- (SBWIRE) -- 05/15/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), Regeneron Pharmaceuticals, Inc....
Read More
from
SBWire - Latest Press Releases
Sanofi (SNY), Regeneron (REGN) Commence COMPARE, ASCERTAIN of Sarilumab
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339115 for the full story.
Read More
from
StreetInsider.com News Articles
Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 15, 2013
Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials
Read More
from
PR Newswire
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right...
Read More
category
Regeneron Pharmaceuticals Inc
,
EOG Resources Inc
,
ENSCO International Incorporated
, and 14 more.
from
CNBC.com News
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Regeneron's Eylea Drives Astounding Q1 Results
May 10, 2013
Regeneron's (REGN) portfolio of drugs is so small as to raise concerns over having too many eggs in one basket. But its blockbuster drug is a crucial treatment for wet macular degeneration, the leading...
Read More
category
Investing
from
Investor's Business Daily - Investing RSS
Recent 52-Week High Exceeded in Shares of Regeneron Pharmaceuticals (REGN)
May 10, 2013
from
Comtex SmarTrend® News Briefs
3 Hot Biotechs to Keep on Your Radar
May 10, 2013
Read More
category
NASDAQ:MEIP
,
NASDAQ:REGN
,
NASDAQ:ICPT
, and 1 more.
from
InvestorPlace - Latest Headlines
MDY, VRTX, REGN, KSU: ETF Outflow Alert
May 08, 2013
Symbols mentioned in this story: MDY, VRTX, REGN, KSU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
The Reason It Trades, What's Moving LLY, MBI, REGN and BMY
May 08, 2013
from
Marketwired News Releases
Regeneron Announces Upcoming 2013 Investor Conference Presentations
May 08, 2013
from
PR Newswire
Regeneron Leads Top 5 Big Cap Stocks By Sales Growth
May 08, 2013
Sales growth is hard to come by in today's sluggish economy. Companies in the big-cap S&P 500 may end up reporting an overall revenue decline in the first quarter. Top-line growth is key continued...
Read More
category
Screen Center
from
Investors.com
NASDAQ Decliners Watch List: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Biogen Idec Inc. (NASDAQ:BIIB) Added to Growing Stock Report's NASDAQ Decline
May 08, 2013
New York, NY -- (SBWIRE) -- 05/08/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ACADIA Pharmaceuticals Inc....
Read More
from
SBWire - Latest Press Releases
Strategy Behind Our Success, We Get in Early: LOW, NWSA, EMC and REGN
May 07, 2013
from
Marketwired News Releases
NASDAQ Decliners Watch List: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and Biogen Idec Inc. (NASDAQ:BIIB) Added to Equity Profile Report's NASDAQ Declin
May 07, 2013
Wilmington, DE -- (SBWIRE) -- 05/07/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), ACADIA Pharmaceuticals Inc....
Read More
from
SBWire - Latest Press Releases
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN) Added to Growing Stock Report's NASDAQ Decliners Watch List.
May 07, 2013
New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN).
Read More
from
SBWire - Latest Press Releases
Midcaps Double S&P 500 Return: Get the Right ETF
May 07, 2013
category
O
,
REGN
,
GE
, and 10 more.
from
YCharts
NASDAQ Decliners Watch List: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 06, 2013
Wilmington, DE -- (SBWIRE) -- 05/06/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Amgen Inc. (NASDAQ:AMGN).
Read More
from
SBWire - Latest Press Releases
UPDATE: Jefferies Raises PT on Regeneron Pharmaceuticals Following Top-Line Q1 Beat
May 06, 2013
In a report published Monday, Jefferies analyst Biren Arnin reiterated a Hold rating on Regeneron Pharmaceuticals (NASDAQ: REGN ), and raised the price target from $179.00 to $247.00. In the report,...
Read More
category
Benzinga
,
REGN
,
Price Target
, and 3 more.
from
Latest Articles from Benzinga.com
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last...
Read More
category
Prime Content
,
AEGR
,
REGN
, and 5 more.
from
Bio-Wire.Com
Stocks Buzz: Regeneron Pharmaceuticals Inc, Swift Transportation Co, Web.com Group Inc, Goodrich Petroleum Corporation
May 06, 2013
Lakeway, NY -- (SBWIRE) -- 05/06/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Free Research Reports on ARNA, REGN, THOR and TWO Issued by the Bedford Report
May 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Regeneron Study: EYLEA Growth Potential
May 06, 2013
Regeneron Pharmaceuticals (NASDAQ: REGN) has received an immense amount of attention in the past year, and has doubled the wealth of shareholders primarily due to the shockingly good performance of the...
Read More
category
REGN
,
Bio/Wire
from
Bio-Wire.Com
< Previous
1
2
3
4
5
6
7
8
9
...
44
45
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here